CH648546A5 - PROCEDURE FOR THE PREPARATION OF CARNITINE ACID CHLORIDE. - Google Patents
PROCEDURE FOR THE PREPARATION OF CARNITINE ACID CHLORIDE. Download PDFInfo
- Publication number
- CH648546A5 CH648546A5 CH3884/82A CH388482A CH648546A5 CH 648546 A5 CH648546 A5 CH 648546A5 CH 3884/82 A CH3884/82 A CH 3884/82A CH 388482 A CH388482 A CH 388482A CH 648546 A5 CH648546 A5 CH 648546A5
- Authority
- CH
- Switzerland
- Prior art keywords
- carnitine
- acid chloride
- chloride
- preparation
- hours
- Prior art date
Links
- PHIQHXFUZVPYII-ZCFIWIBFSA-O (R)-carnitinium Chemical compound C[N+](C)(C)C[C@H](O)CC(O)=O PHIQHXFUZVPYII-ZCFIWIBFSA-O 0.000 title claims description 26
- 229960004203 carnitine Drugs 0.000 title claims description 26
- NGNBDVOYPDDBFK-UHFFFAOYSA-N 2-[2,4-di(pentan-2-yl)phenoxy]acetyl chloride Chemical compound CCCC(C)C1=CC=C(OCC(Cl)=O)C(C(C)CCC)=C1 NGNBDVOYPDDBFK-UHFFFAOYSA-N 0.000 title claims description 15
- 238000000034 method Methods 0.000 title claims description 7
- 238000002360 preparation method Methods 0.000 title description 4
- FYSNRJHAOHDILO-UHFFFAOYSA-N thionyl chloride Chemical compound ClS(Cl)=O FYSNRJHAOHDILO-UHFFFAOYSA-N 0.000 claims description 14
- 239000012320 chlorinating reagent Substances 0.000 claims description 9
- CTSLXHKWHWQRSH-UHFFFAOYSA-N oxalyl chloride Chemical compound ClC(=O)C(Cl)=O CTSLXHKWHWQRSH-UHFFFAOYSA-N 0.000 claims description 6
- 230000035484 reaction time Effects 0.000 claims description 6
- HKYGSMOFSFOEIP-UHFFFAOYSA-N dichloro(dichloromethoxy)methane Chemical compound ClC(Cl)OC(Cl)Cl HKYGSMOFSFOEIP-UHFFFAOYSA-N 0.000 claims description 5
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 13
- PHIQHXFUZVPYII-UHFFFAOYSA-N carnitine Chemical compound C[N+](C)(C)CC(O)CC([O-])=O PHIQHXFUZVPYII-UHFFFAOYSA-N 0.000 description 9
- 238000006243 chemical reaction Methods 0.000 description 9
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 6
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 6
- 239000002253 acid Substances 0.000 description 6
- GUYHPGUANSLONG-SNAWJCMRSA-N (E)-4-(trimethylammonio)but-2-enoate Chemical compound C[N+](C)(C)C\C=C\C([O-])=O GUYHPGUANSLONG-SNAWJCMRSA-N 0.000 description 5
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 5
- 150000004702 methyl esters Chemical class 0.000 description 5
- 230000015572 biosynthetic process Effects 0.000 description 4
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 3
- 235000011114 ammonium hydroxide Nutrition 0.000 description 3
- 239000006227 byproduct Substances 0.000 description 3
- 229960000678 carnitine chloride Drugs 0.000 description 3
- 238000000655 nuclear magnetic resonance spectrum Methods 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- WHBMMWSBFZVSSR-UHFFFAOYSA-N 3-hydroxybutyric acid Chemical compound CC(O)CC(O)=O WHBMMWSBFZVSSR-UHFFFAOYSA-N 0.000 description 2
- 125000000218 acetic acid group Chemical group C(C)(=O)* 0.000 description 2
- 230000002378 acidificating effect Effects 0.000 description 2
- 150000001277 beta hydroxy acids Chemical class 0.000 description 2
- 230000015556 catabolic process Effects 0.000 description 2
- 238000005660 chlorination reaction Methods 0.000 description 2
- 238000006731 degradation reaction Methods 0.000 description 2
- 230000018044 dehydration Effects 0.000 description 2
- 238000006297 dehydration reaction Methods 0.000 description 2
- 150000002148 esters Chemical class 0.000 description 2
- 239000011541 reaction mixture Substances 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 229910006124 SOCl2 Inorganic materials 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 150000001408 amides Chemical class 0.000 description 1
- 244000309464 bull Species 0.000 description 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
- 150000001732 carboxylic acid derivatives Chemical class 0.000 description 1
- -1 carnitine methyl ester Chemical class 0.000 description 1
- 150000001805 chlorine compounds Chemical class 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 239000007857 degradation product Substances 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- VNWKTOKETHGBQD-UHFFFAOYSA-N methane Natural products C VNWKTOKETHGBQD-UHFFFAOYSA-N 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- UHZYTMXLRWXGPK-UHFFFAOYSA-N phosphorus pentachloride Chemical compound ClP(Cl)(Cl)(Cl)Cl UHZYTMXLRWXGPK-UHFFFAOYSA-N 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 230000007928 solubilization Effects 0.000 description 1
- 238000005063 solubilization Methods 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 125000000475 sulfinyl group Chemical group [*:2]S([*:1])=O 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 230000001131 transforming effect Effects 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C213/00—Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton
- C07C213/08—Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton by reactions not involving the formation of amino groups, hydroxy groups or etherified or esterified hydroxy groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
- C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
- C07C229/04—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
- C07C229/22—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated the carbon skeleton being further substituted by oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C1/00—Preparation of hydrocarbons from one or more compounds, none of them being a hydrocarbon
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C227/00—Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C227/00—Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton
- C07C227/14—Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton from compounds containing already amino and carboxyl groups or derivatives thereof
- C07C227/18—Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton from compounds containing already amino and carboxyl groups or derivatives thereof by reactions involving amino or carboxyl groups, e.g. hydrolysis of esters or amides, by formation of halides, salts or esters
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C51/00—Preparation of carboxylic acids or their salts, halides or anhydrides
- C07C51/347—Preparation of carboxylic acids or their salts, halides or anhydrides by reactions not involving formation of carboxyl groups
- C07C51/363—Preparation of carboxylic acids or their salts, halides or anhydrides by reactions not involving formation of carboxyl groups by introduction of halogen; by substitution of halogen atoms by other halogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
- C07C59/01—Saturated compounds having only one carboxyl group and containing hydroxy or O-metal groups
- C07C59/115—Saturated compounds having only one carboxyl group and containing hydroxy or O-metal groups containing halogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C67/00—Preparation of carboxylic acid esters
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Description
La presente invenzione riguarda un procedimento per la preparazione del cloruro acido di D,L-carnitina, The present invention relates to a process for the preparation of the acid chloride of D, L-carnitine,
(CH3)3N-CH2-CH-CH2-COCl (CH3) 3N-CH2-CH-CH2-COCl
I THE
OH OH
Il cloruro acido di D,L-carnitina è un versatile intermedio per la preparazione di diversi derivati della carnitina, ad esempio di esteri ed ammidi, di cui sono note le applicazioni terapeutiche. The acid chloride of D, L-carnitine is a versatile intermediate for the preparation of various carnitine derivatives, for example esters and amides, whose therapeutic applications are known.
La carnitina, Carnitine,
(CH3)3N-CH2-CH-CH2-COOH (CH3) 3N-CH2-CH-CH2-COOH
i the
OH OH
contiene oltre alla funzione carbossilica anche la funzione ossidrilica che è notoriamente sensibile agli ambienti di reazione acidi. in addition to the carboxylic function it also contains the hydroxyl function which is known to be sensitive to acidic reaction environments.
Infatti è noto, ad esempio da Bull. Soc. Chim. Fr. (1960) 1196, che i ß-idrossi acidi ed i loro esteri eliminano molto facilmente in ambiente acido una molecola d'acqua formando dei composti insaturi. In Biochim. Biophys. Acta 137, 98-106 (1967) e 152, 559 (1968) si descrive la disidratazione della carnitina a caldo in ambiente acido. In J. Biol. Chem. 237/12, 3628 (1962) si descrive la formazione di crotonoilbetaina quale prodotto secondario per trattamento della carnitina a caldo in ambiente acido. In fact it is known, for example from Bull. Soc. Chim. Fr. (1960) 1196, that ß-hydroxy acids and their esters very easily eliminate a water molecule in an acid medium by forming unsaturated compounds. In Biochim. Biophys. Acta 137, 98-106 (1967) and 152, 559 (1968) describe the dehydration of hot carnitine in an acid medium. In J. Biol. Chem. 237/12, 3628 (1962) describes the formation of crotonoylbetaine as a secondary product for hot carnitine treatment in an acid medium.
Poiché la conversione di un acido carbossilico in cloruro acido avviene in condizioni acide, sarebbe logico attendersi che la clorurazione della carnitina non possa avvenire senza previa protezione del grappo ossidrilico, allo scopo di evitare la degradazione del prodotto di partenza e la formazione di sottoprodotti non desiderati. Ciò è pienamente confermato da quanto desumibile dalla tecnica nota. In J. Org. Chem. 43/20, 3972 (1978) si descrive la preparazione di cloruri acidi di acidi idrossisostituiti dopo previa protezione del gruppo ossidrilico. Più particolarmente, in J. Am. Chem. Soc. 95, 4016 (1973) si descrive la clorurazione del-Facido ß-idrossibutirrico (un ß-idrossiacido qual'è appunto la carnitina) dopo aver protetto il gruppo ossidrilico con un acetile. Since the conversion of a carboxylic acid into acid chloride takes place in acidic conditions, it would be logical to expect that carnitine chlorination cannot take place without prior protection of the hydroxyl group, in order to avoid degradation of the starting product and the formation of unwanted by-products . This is fully confirmed by what can be deduced from the prior art. In J. Org. Chem. 43/20, 3972 (1978) describes the preparation of acid chlorides of hydroxy-substituted acids after prior protection of the hydroxy group. More particularly, in J. Am. Chem. Soc. 95, 4016 (1973) describes the chlorination of the ß-hydroxybutyric acid (a ß-hydroxyacid such as carnitine) after protecting the hydroxy group with an acetyl.
È stato ora sorprendentemente provato che è possibile convertire D,L-carnitina in cloruro acido di D,L-carnitina con rese eccellenti, senza che si formino quantità industrialmente inaccettabili di sottoprodotti, in particolare di crotonoilbetaina, clorurando la D,L-carnitina senza previamente proteggere il gruppo ossidrilico (trasformandolo ad esempio in acetile come insegnato nella tecnica nota), purché vengano osservate certe condizioni operative critiche. It has now been surprisingly proven that it is possible to convert D, L-carnitine to acid chloride of D, L-carnitine with excellent yields, without industrially unacceptable quantities of by-products being produced, in particular crotonoylbetaine, by chlorinating D, L-carnitine without previously protect the hydroxy group (transforming it for example into acetyl as taught in the prior art), provided that certain critical operating conditions are observed.
Si è infatti trovato che il rapporto molare carnitina/agente clorurante, la temperatura di reazione ed il tempo di reazione sono i parametri critici influenti la conversione di D,L carnitina nel corrispondente cloruro acido e che i valori assunti da tali parametri devono rientrare in intervalli ben definiti. It has in fact been found that the carnitine / chlorinating agent molar ratio, the reaction temperature and the reaction time are the critical parameters influencing the conversion of D, L carnitine into the corresponding acid chloride and that the values assumed by these parameters must fall within ranges well defined.
In accordo all'invenzione, il procedimento per convertire carnitina nel cloruro acido di carnitina comprende lo stadio di: clorurare carnitina con un agente clorurante, preferibilmente scelto fra cloruro di tionile, diclorometiletere e 5 ossalilcloruro, a temperatura ambiente per tempi di reazione compresi fra circa 1,5 e 12 ore. According to the invention, the process for converting carnitine into carnitine acid chloride comprises the step of: chlorinating carnitine with a chlorinating agent, preferably selected from thionyl chloride, dichloromethyl ether and 5 oxalyl chloride, at room temperature for reaction times ranging from about 1.5 and 12 hours.
Quale agente clorurante si potrebbe usare anche il penta-cloruro di fosforo, che tuttavia non si fa preferire a causa dei tempi di reazione (1-3 giorni) nettamente superiori a io quelli sopraindicati. Phosphorus penta-chloride could also be used as a chlorinating agent, which, however, is not preferred due to the reaction times (1-3 days) clearly higher than those indicated above.
Preferibilmente, il rapporto molare carnitina/agente clorurante è compreso fra 1:1 e 1:3. Allo scopo di ottenere con alte rese la conversione della carnitina nel cloruro acido è essenziale che vengano rispettati la temperatura ed i ternis pi di reazione sopraindicati, scostamenti anche lievi provocando la formazione di sottoprodotti. Ad esempio, usando ossalilcloruro quale agente clorurante, con un tempo di reazione di 15 ore si ottiene la quasi totale degradazione della carnitina in cotonoilbetaina. Preferably, the carnitine / chlorinating agent molar ratio is between 1: 1 and 1: 3. In order to obtain the conversion of carnitine into acid chloride with high yields, it is essential that the above mentioned temperature and reaction ternis be respected, even slight deviations causing the formation of by-products. For example, using oxalyl chloride as a chlorinating agent, with a reaction time of 15 hours, the almost total degradation of carnitine into cotonoylbetaine is obtained.
20 Gli esempi non limitativi 1 e 2 che seguono illustrano il procedimento della presente invenzione. 20 The non-limiting examples 1 and 2 that follow illustrate the process of the present invention.
Esempio 1 (agente clorurante: cloniro di tionile) 2,25 cc (0,03 moli) di SOCl2 vennero aggiunti a 1,98 g 25 (0,01 moli) di D,L-carnitina cloruro. Dopo 1 ora la solubi-lizzazione era completa e dopo 1,5 ore la reazione poteva considerarsi finita. Si distillò il SOCl2 in eccesso e si lavò il residuo costituito dal cloruro acido di carnitina con etere etilico anidro. A scopo di controllo, si trasformò il cloruro 30 acido in estere metilico: si raffreddò a 0°C e si aggiunsero goccia a goccia 10 cc di metanolo anidro; quindi, si concentrò sotto vuoto a 35-40°C e si ottenne un grezzo gelatinoso che essiccato sotto vuoto solidificò rimanendo tuttavia molto igroscopico. Example 1 (chlorinating agent: thionyl cloniro) 2.25 cc (0.03 moles) of SOCl2 was added to 1.98 g 25 (0.01 moles) of D, L-carnitine chloride. After 1 hour the solubilization was complete and after 1.5 hours the reaction could be considered finished. The excess SOC1 was distilled and the residue consisting of the acid carnitine chloride was washed with anhydrous ethyl ether. For control purposes, the acid chloride 30 was transformed into methyl ester: it was cooled to 0 ° C and 10 cc of anhydrous methanol were added drop by drop; then, it was concentrated under vacuum at 35-40 ° C and a gelatinous crude was obtained which dried under vacuum solidified while remaining very hygroscopic.
35 35
T.L.C, cloroformio 55/Metanolo 35/H20 5/NH4OH 5 Spettro NMR Solvente D20 T.L.C, chloroform 55 / Methanol 35 / H20 5 / NH4OH 5 NMR spectrum Solvent D20
4,82 (lH,m,-CH-); 3,83 (3H,s,-OCHs); 3,55 (2H,d, -» « | N+CH2-); 4.82 (1H, m, -CH-); 3.83 (3H, s, -OCHs); 3.55 (2H, d, - »« | N + CH2-);
OH OH
3,30 (9H,s,-N+= 3.30 (9H, s, -N + =
CH3 CH3
-CH3); 2,73 (2H,d,-CH2CO-). ~CH3 CH3); 2.73 (2H, d, -CH2CO-). ~ CH3
Analisi elementare: Calcolato Elementary analysis: Calculated
50 50
C H N CI C H N CI
45,39 8,57 6,62 16,75 45.39 8.57 6.62 16.75
Trovato Found
43,99 8,54 6,09 16,92 43.99 8.54 6.09 16.92
K. F. ~ 4% K. F. ~ 4%
Esempio 2 (agente clorurante: diclorometiletere) 55 Si operò come nell'esempio precedente, tranne che in luogo del cloruro di tionile si impiegò diclorometiletere (1,78 cc; 0,02 moli). La miscela di reazione venne lasciata per una notte a temperatura ambiente. Si distillò il diclorometiletere in eccesso e si lavò il residuo con etere etilico 60 anidro. Il residuo risultò costituito da cloruro acido di carnitina. Example 2 (chlorinating agent: dichloromethyl ether) 55 The same procedure was used as in the previous example, with the exception of dichloromethyl ether (1.78 cc; 0.02 moles) was used instead of thionyl chloride. The reaction mixture was left overnight at room temperature. The excess dichloromethyl ether was distilled and the residue was washed with anhydrous ethyl ether 60. The residue was made up of carnitine acid chloride.
CH3 CH3
NMR CDSCN 8 3,33 (9H,s,CH3^N+-); 3,36-3,60 (4H,m,-* NMR CDSCN 8 3.33 (9H, s, CH3 ^ N + -); 3.36-3.60 (4H, m, - *
CH3 CH3
65 65
N+-CH2-, -CH2COCl); 4,40-4,90 (lH,m,-CH-) N + -CH2-, -CH2COCl); 4.40-4.90 (lH, m, -CH-)
OH OH
3 3
648546 648546
Dopo scambio con D20 i chemical shifts ritornavano ad avere gli stessi valori dello spettro NMR della carnitina. Il cloruro acido grzzo venne trasformato successivamente in estere metilico come precedentemente descritto. L'estere metilico della carnitina mostrava le caratteristiche chimico fisiche corrispondenti al prodotto precedentemente isolato. After exchange with D20 the chemical shifts returned to have the same values as the NMR spectrum of carnitine. The crude acid chloride was subsequently transformed into methyl ester as previously described. The methyl ester of carnitine showed the chemical-physical characteristics corresponding to the previously isolated product.
Gli esempi A e B che seguono servono ad illustrare l'assoluta criticità delle condizioni operative indicate allo scopo di ottenere il cloruro acido di carnitina. Examples A and B below serve to illustrate the absolute criticality of the operating conditions indicated for the purpose of obtaining carnitine acid chloride.
Esempio A Example A
(mancata osservanza dell'appropriata temperatura di reazione) (failure to observe the appropriate reaction temperature)
Una miscela di carnitina e cloruro di tionile nel rapporto molare 1:1 venne mantenuta sotto agitazione a 50°C. Vennero fatti dei prelievi ai tempi successivi di 0,5 ore, 1 ora, 1,5 ore. I campioni prelevati vennero esaminati mediante TLC (cloroformio 55/CH3OH 35/ H20 5/ NH4OH 5') dopo diluizione con metanolo per trasformare l'eventuale cloruro acido in estere metilico. A mixture of carnitine and thionyl chloride in the molar ratio 1: 1 was kept under stirring at 50 ° C. Withdrawals were made in the following times of 0.5 hours, 1 hour, 1.5 hours. The samples taken were examined by TLC (chloroform 55 / CH3OH 35 / H20 5 / NH4OH 5 ') after dilution with methanol to transform any acid chloride into methyl ester.
Dopo 0,5 ore si notò la presenza di carnitina e estere metilico di carnitina. Rf 0,4-0,8 rispettivamente. After 0.5 hours the presence of carnitine and carnitine methyl ester was noted. Rf 0.4-0.8 respectively.
Dopo 1 ora si cominciò a formare crotonoilbetaina più carnitina e estere metilico di carnitina Rf 0,2-0,4-0,8 rispettivamente. After 1 hour, crotonoylbetaine plus carnitine and methyl ester of carnitine Rf 0.2-0.4-0.8 began to form respectively.
Dopo 1,5 ore si notò la presenza di crotonoilbetaina più altri prodotti di degradazione non identificabili. After 1.5 hours, the presence of crotonoylbetaine plus other unidentifiable degradation products was noted.
Esempio B Example B
(mancata osservanza dell'appropriato tempo di reazione) (failure to observe the appropriate reaction time)
Cloruro di tionile (2,3 cc; 0,03 moli) venne aggiunto a s carnitina cloruro (1,98 g; 0,01 moli) e la risultante miscela di reazione venne mantenuta a temperatura ambiente sotto agitazione per 24 ore. Il cloruro di tionile in eccesso venne distillato e il residuo grezzo venne lavato con etere etilico anidro con ottenimento di un solido avente punto di fusione io 217-218°C. Thionyl chloride (2.3 cc; 0.03 moles) was added to s carnitine chloride (1.98 g; 0.01 moles) and the resulting reaction mixture was kept at room temperature under stirring for 24 hours. The excess thionyl chloride was distilled and the crude residue was washed with anhydrous ethyl ether to obtain a solid having a melting point of 217-218 ° C.
T.L.C, cloroformio 55/ Metanolo 35/ H20 5/ NH4OH 5/ Rf 0,2. T.L.C, chloroform 55 / Methanol 35 / H20 5 / NH4OH 5 / Rf 0.2.
15 NMR D20 S 7,2-6,2 (2H,m,-CH=CH-); 4,2 (2H,d, -» 15 NMR D20 S 7.2-6.2 (2H, m, -CH = CH-); 4.2 (2H, d, - "
CH3 CH3
N+-CH2-); 3,2 (9H,s,CH3^N+-). N + -CH2-); 3.2 (9H, s, CH3 ^ N + -).
ch3 ch3
20 20
Come risulta da TLC e dallo spettro NMR in queste condizioni di reazione non si è formato il cloruro acido di carnitina ma è avvenuta una disidratazione con formazione di crotonoilbetaina As shown by TLC and the NMR spectrum in these reaction conditions carnitine acid chloride was not formed but dehydration with crotonoylbetaine formation occurred
25 25
ch3 ch3
CH35=N+-CH2-CH=CH-COOH CH35 = N + -CH2-CH = CH-COOH
ch3 ci- ch3 ci-
Claims (2)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IT48817/81A IT1171360B (en) | 1981-07-03 | 1981-07-03 | PROCEDURE FOR THE PREPARATION OF CARNITINE ACID CHLORIDE |
Publications (1)
Publication Number | Publication Date |
---|---|
CH648546A5 true CH648546A5 (en) | 1985-03-29 |
Family
ID=11268676
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CH3884/82A CH648546A5 (en) | 1981-07-03 | 1982-06-24 | PROCEDURE FOR THE PREPARATION OF CARNITINE ACID CHLORIDE. |
Country Status (18)
Country | Link |
---|---|
JP (1) | JPS5815943A (en) |
KR (1) | KR860001886B1 (en) |
AT (1) | AT390057B (en) |
BE (1) | BE893713A (en) |
CA (1) | CA1186332A (en) |
CH (1) | CH648546A5 (en) |
DE (1) | DE3224666A1 (en) |
DK (1) | DK154425C (en) |
ES (1) | ES513658A0 (en) |
FR (1) | FR2510559B1 (en) |
GB (1) | GB2101133B (en) |
GR (1) | GR76546B (en) |
IE (1) | IE53279B1 (en) |
IL (1) | IL66251A0 (en) |
IT (1) | IT1171360B (en) |
LU (1) | LU84244A1 (en) |
NL (1) | NL189666C (en) |
SE (1) | SE448724B (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IT1190358B (en) * | 1985-05-24 | 1988-02-16 | Sclavo Spa | PROCEDURE FOR THE PREPARATION OF L-CARNITINA |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3940439A (en) * | 1973-11-14 | 1976-02-24 | G. D. Searle & Co. | Acid chloride synthesis |
IT1116037B (en) * | 1979-04-23 | 1986-02-10 | Sigma Tau Ind Farmaceuti | ACIL CARNITINE ESTERS AND AMIDS THEIR PREPARATION PROCEDURES AND THERAPEUTIC USE |
DE2943433A1 (en) * | 1979-10-26 | 1981-05-07 | Bayer Ag, 5090 Leverkusen | METHOD FOR PRODUCING CARBONIC ACID HALOGENIDES |
-
1981
- 1981-07-03 IT IT48817/81A patent/IT1171360B/en active
-
1982
- 1982-06-24 CH CH3884/82A patent/CH648546A5/en not_active IP Right Cessation
- 1982-06-25 IE IE1524/82A patent/IE53279B1/en not_active IP Right Cessation
- 1982-06-29 GB GB08218824A patent/GB2101133B/en not_active Expired
- 1982-06-30 LU LU84244A patent/LU84244A1/en unknown
- 1982-06-30 DK DK295482A patent/DK154425C/en not_active IP Right Cessation
- 1982-06-30 CA CA000406463A patent/CA1186332A/en not_active Expired
- 1982-06-30 BE BE0/208502A patent/BE893713A/en not_active IP Right Cessation
- 1982-07-01 GR GR68615A patent/GR76546B/el unknown
- 1982-07-01 DE DE19823224666 patent/DE3224666A1/en active Granted
- 1982-07-01 KR KR8202945A patent/KR860001886B1/en active
- 1982-07-02 AT AT0257382A patent/AT390057B/en not_active IP Right Cessation
- 1982-07-02 ES ES513658A patent/ES513658A0/en active Granted
- 1982-07-02 JP JP57116084A patent/JPS5815943A/en active Granted
- 1982-07-02 SE SE8204117A patent/SE448724B/en not_active IP Right Cessation
- 1982-07-02 FR FR8211685A patent/FR2510559B1/en not_active Expired
- 1982-07-02 NL NLAANVRAGE8202677,A patent/NL189666C/en not_active IP Right Cessation
- 1982-07-07 IL IL66251A patent/IL66251A0/en not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
KR840000475A (en) | 1984-02-22 |
DE3224666C2 (en) | 1991-01-24 |
IE821524L (en) | 1983-01-03 |
JPH0244300B2 (en) | 1990-10-03 |
GR76546B (en) | 1984-08-10 |
BE893713A (en) | 1982-10-18 |
DK295482A (en) | 1983-01-04 |
SE8204117D0 (en) | 1982-07-02 |
DE3224666A1 (en) | 1983-01-20 |
IT1171360B (en) | 1987-06-10 |
NL189666C (en) | 1993-06-16 |
AT390057B (en) | 1990-03-12 |
JPS5815943A (en) | 1983-01-29 |
IL66251A0 (en) | 1982-11-30 |
DK154425C (en) | 1989-04-10 |
SE448724B (en) | 1987-03-16 |
IE53279B1 (en) | 1988-09-28 |
IT8148817A0 (en) | 1981-07-03 |
DK154425B (en) | 1988-11-14 |
FR2510559A1 (en) | 1983-02-04 |
SE8204117L (en) | 1983-01-04 |
NL189666B (en) | 1993-01-18 |
FR2510559B1 (en) | 1986-05-09 |
ES8304064A1 (en) | 1983-03-01 |
GB2101133A (en) | 1983-01-12 |
GB2101133B (en) | 1985-08-14 |
ES513658A0 (en) | 1983-03-01 |
LU84244A1 (en) | 1983-01-20 |
CA1186332A (en) | 1985-04-30 |
ATA257382A (en) | 1989-08-15 |
KR860001886B1 (en) | 1986-10-24 |
NL8202677A (en) | 1983-02-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE3527241A1 (en) | Process for the preparation of 3-substituted 1-amino-2-hydroxypropane derivatives | |
CH648546A5 (en) | PROCEDURE FOR THE PREPARATION OF CARNITINE ACID CHLORIDE. | |
DE2539116C2 (en) | ? -Nor-cycloalkyl-13,14-dehydro-prostaglandins, processes for their preparation and pharmaceutical compositions containing them | |
KR100357651B1 (en) | Process for the preparation of shikimic acid and its salts | |
GB2127013A (en) | Tetrafluoroterephthalyl alcohol, esters thereof and a process for their preparation | |
US5618959A (en) | Process for preparing prostaglandin E1, E2 and analogs thereof using furylcopper reagents | |
DE2533335C2 (en) | 3-Methyl-3-aryl-pyruvic acid esters and process for the preparation of substituted pyruvic acid esters | |
DE2533387C2 (en) | Process for the preparation of 2-hydroxy-3-butenoic acid esters | |
EP0294774A3 (en) | Process for the preparation of gamma-halogen tiglinic acid alkylesters and their subsequent processing to 0,0-dialkyl-gamma-phosphono-alkyl tiglinic acid alkyl esters | |
DE69014378T2 (en) | Intermediates, usable for the synthesis of delphinidine chloride. | |
DE2257867A1 (en) | PROCESS FOR MANUFACTURING INDOLDER DERIVATIVES | |
DE2404159A1 (en) | PROCESS FOR THE PRODUCTION OF 2-PHENYLPROPIONIC ACID DERIVATIVES | |
KR800001045B1 (en) | Method for the preparation of 2-(4'-alkylphenyl)propion aldehyde | |
CN109232240B (en) | Method for synthesizing chloroacrylic acid fluoroalcohol ester | |
US2644830A (en) | Vanillimino ethyl ether and its salts of anhydrous acids | |
US2459059A (en) | Method for preparing alkyl acyloxy acrylates | |
US4249015A (en) | Preparation of organic acids and/or esters | |
KR880001842B1 (en) | Process for the preparation of ethyl-4,6,6,6-tetrachloro-3,3,-dimethyl hexenoate | |
KR19990006498A (en) | Method for preparing 1-bromoethyl acetate | |
DD209617A5 (en) | PROCESS FOR PREPARING OPTICALLY ACTIVE 1- (6-METHOXY-2-NAPHTHYL) -2- (ALKOXYCARBONYL) -AMINO-PROPANONE AND ITS DERIVATIVES AND HALOGEN ANALOGUES | |
US4845271A (en) | Process for the preparation of omega-unsaturated carboxylic acids | |
US4149010A (en) | Synthesis of α-trifluoromethyl vinyl acetate | |
DE2802387C2 (en) | Process for the preparation of thiazo-üdin-4-one-acetic acid derivatives | |
CN116120238A (en) | Preparation method of imidazole derivative | |
JPH05310638A (en) | Production of unsaturated fatty acid triglyceride |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PL | Patent ceased |